Skip to main content

Closed

TCRX: TScan Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.35×avg

Market Cap

45.38MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

TScan Therapeutics, Inc.

TCRXNASDAQ·USD·Closed

TScan Therapeutics, Inc.

TCRXNASDAQ·USD·Closed

$0.74

−1.68%

$0.74

−$0.01 (1.68%)

52W Range

1thpctl

Volume

0.35×avg

Mkt Cap

45.38MUSD

P/E

-0.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings